Valuation : Sysmex Corporation

Market Cap 1,081B 7.04B 6.07B 5.74B 5.21B 9.77B 673B 9.82B 68.21B 26.23B 342B 26.44B 25.86B P/E 2027 *
26.9x
P/E 2028 * 21.1x
Enterprise Value 1,104B 7.19B 6.19B 5.86B 5.31B 9.97B 686B 10.02B 69.62B 26.77B 349B 26.99B 26.39B EV / Sales 2027 *
2.02x
EV / Sales 2028 * 1.92x
Free-Float
72.3%
Yield 2027 *
2.27%
Yield 2028 * 2.31%
1 day+0.42%
1 week-8.29%
Current month-8.99%
1 month-7.72%
3 months+27.11%
6 months+27.02%
Current year+15.82%
1 week 1,737
Extreme 1737
1,939
1 month 1,737
Extreme 1737
2,012.5
Current year 1,246
Extreme 1246
2,012.5
1 year 1,246
Extreme 1246
2,012.5
3 years 1,246
Extreme 1246
3,236
5 years 1,246
Extreme 1246
5,241.67
10 years 1,246
Extreme 1246
5,241.67
Manager TitleAgeSince
Chief Executive Officer 77 01/04/2018
Director of Finance/CFO 56 -
President 65 01/04/2026
Director TitleAgeSince
Chairman 77 01/04/2013
Director/Board Member 65 01/06/2019
Director/Board Member 71 01/06/2019
Change 5-day change 1-year change 3-year change Capi.($)
+0.42%-8.29%-5.53%-30.03% 7.04B
-1.36%-5.89%-23.76%-0.44% 176B
-0.72%-3.41%-3.26%+12.32% 116B
+0.19%-2.83%+6.30%+80.17% 61.36B
-1.92%-6.01%+7.05%+38.44% 49.42B
+0.81%-3.73%-4.81%-32.56% 48.44B
-1.75%-5.54%+8.93%-20.82% 31.33B
+0.43%-11.10% - - 28.54B
+0.58%+1.84%+36.58%-12.08% 24.37B
+0.49%-7.65%-13.30%+3.79% 21.57B
Average -0.28%-5.40%+0.91%+4.31% 56.48B
Weighted average by Cap. -0.68%-4.94%-6.01%+10.30%

Financials

2027 *2028 *
Net sales 546B 3.56B 3.07B 2.9B 2.63B 4.94B 340B 4.96B 34.47B 13.26B 173B 13.36B 13.07B 573B 3.73B 3.22B 3.04B 2.76B 5.18B 357B 5.2B 36.16B 13.91B 181B 14.02B 13.71B
Net income 41.19B 268M 231M 219M 198M 372M 25.62B 374M 2.6B 999M 13.03B 1.01B 985M 51.74B 337M 290M 275M 249M 467M 32.18B 470M 3.26B 1.26B 16.37B 1.27B 1.24B
Net Debt 22.37B 146M 125M 119M 108M 202M 13.91B 203M 1.41B 543M 7.08B 547M 535M 21.54B 140M 121M 114M 104M 195M 13.4B 196M 1.36B 523M 6.82B 527M 515M
Logo Sysmex Corporation
Sysmex Corp is a Japan-based company principally engaged in the health care business. The Company conducts product development, manufacturing, sales, and service in domestic markets, and some products are developed, manufactured, and sold by subsidiaries. Overseas, the Company conducts the manufacturing and sales of products in the Americas, EMEA, China, and Asia Pacific through other companies. Along with its subsidiaries, the Company is involved in the development, manufacture, sale and service of clinical laboratory equipment, laboratory test drugs and products related to laboratory test.
Employees
10,861
Date Price Change Volume
11/09/26 ¥1,786.50 +0.42% 2,997,600
10/09/26 ¥1,779.00 -2.15% 3,137,400
09/09/26 ¥1,818.00 -1.46% 2,653,300
08/09/26 ¥1,845.00 -2.51% 2,407,400
07/09/26 ¥1,892.50 -2.85% 2,787,800
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
1,786.50JPY
Average target price
2,060.71JPY
Spread / Average Target
+15.35%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 6869 Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!